Your browser doesn't support javascript.
loading
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.
Yanagihara, Katsunori; Matsumoto, Tetsuya; Aoki, Nobuki; Sato, Junko; Wakamura, Tomotaro; Kiyota, Hiroshi; Tateda, Kazuhiro; Hanaki, Hideaki; Ohsaki, Yoshinobu; Fujiuchi, Satoru; Takahashi, Manabu; Akiba, Yuji; Masunaga, Shingo; Takeuchi, Kenichi; Takeda, Hiroaki; Miki, Makoto; Kumagai, Toshio; Takahashi, Hiroshi; Utagawa, Mutsuko; Nishiya, Hajime; Kawakami, Sayoko; Ishigaki, Shinobu; Kobayasi, Nobuyuki; Takasaki, Jin; Mezaki, Kazuhisa; Iwata, Satoshi; Katouno, Yasuhiro; Inose, Rika; Niki, Yoshihito; Kawana, Akihiko; Fujikura, Yuji; Kudo, Makoto; Hirano, Tomo; Yamamoto, Masaki; Miyazawa, Naoki; Tsukada, Hiroki; Aso, Sakura; Yamamoto, Yoshihiro; Iinuma, Yoshitsugu; Mikamo, Hiroshige; Yamagishi, Yuka; Nakamura, Atsushi; Ohashi, Minoru; Kawabata, Atsushi; Sugaki, Yoshiko; Seki, Masafumi; Hamaguchi, Shigeto; Toyokawa, Masahiro; Kakeya, Hiroshi; Fujikawa, Yasunori.
  • Yanagihara K; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan; Nagasaki University School of Medicine, Nagasaki, Japan. Electronic address: k-yanagi@nagasaki-u.ac.j
  • Matsumoto T; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.
  • Aoki N; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.
  • Sato J; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.
  • Wakamura T; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.
  • Kiyota H; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.
  • Tateda K; The Surveillance Committee of Japanese Society of Chemotherapy (JSC), The Japanese Association for Infectious Diseases (JAID) and the Japanese Society for Clinical Microbiology (JSCM), Tokyo, Japan.
  • Hanaki H; The Kitasato Institute, Tokyo, Japan.
  • Ohsaki Y; Asahikawa Medical University, Hokkaido, Japan.
  • Fujiuchi S; National Hospital Organization Asahikawa Medical Center, Hokkaido, Japan.
  • Takahashi M; National Hospital Organization Asahikawa Medical Center, Hokkaido, Japan.
  • Akiba Y; Asahikawa Kosei Hospital, Hokkaido, Japan.
  • Masunaga S; Asahikawa Kosei Hospital, Hokkaido, Japan.
  • Takeuchi K; Iwate Prefectural Central Hospital, Iwate, Japan.
  • Takeda H; Saiseikai Yamagata Saisei Hospital, Yamagata, Japan.
  • Miki M; Japanese Red Cross Sendai Hospital, Miyagi, Japan.
  • Kumagai T; Japanese Red Cross Sendai Hospital, Miyagi, Japan.
  • Takahashi H; Saka General Hospital, Miyagi, Japan.
  • Utagawa M; Saka General Hospital, Miyagi, Japan.
  • Nishiya H; Teikyo University Hospital, Tokyo, Japan.
  • Kawakami S; Teikyo University Hospital, Tokyo, Japan.
  • Ishigaki S; Teikyo University Hospital, Tokyo, Japan.
  • Kobayasi N; National Center for Global Health and Medicine, Tokyo, Japan.
  • Takasaki J; National Center for Global Health and Medicine, Tokyo, Japan.
  • Mezaki K; National Center for Global Health and Medicine, Tokyo, Japan.
  • Iwata S; Keio University Hospital, Tokyo, Japan.
  • Katouno Y; Keio University Hospital, Tokyo, Japan.
  • Inose R; Keio University Hospital, Tokyo, Japan.
  • Niki Y; Showa University School of Medicine, Tokyo, Japan.
  • Kawana A; National Defense Medical College Hospital, Saitama, Japan.
  • Fujikura Y; National Defense Medical College Hospital, Saitama, Japan.
  • Kudo M; Yokohama City University Hospital, Kanagawa, Japan.
  • Hirano T; Yokohama City University Hospital, Kanagawa, Japan.
  • Yamamoto M; Yokohama City University Hospital, Kanagawa, Japan.
  • Miyazawa N; Saiseikai Yokohamashi Nanbu Hospital, Kanagawa, Japan.
  • Tsukada H; Niigata City General Hospital, Niigata, Japan.
  • Aso S; Niigata City General Hospital, Niigata, Japan.
  • Yamamoto Y; Toyama University Hospital, Toyama, Japan.
  • Iinuma Y; Kanazawa Medical University, Ishikawa, Japan.
  • Mikamo H; Aichi Medical University Hospital, Aichi, Japan.
  • Yamagishi Y; Aichi Medical University Hospital, Aichi, Japan.
  • Nakamura A; Nagoya City University Hospital, Aichi, Japan.
  • Ohashi M; Nagoya City University Hospital, Aichi, Japan.
  • Kawabata A; Toyota Memorial Hospital, Aichi, Japan.
  • Sugaki Y; Toyota Memorial Hospital, Aichi, Japan.
  • Seki M; Osaka University Hospital, Osaka, Japan.
  • Hamaguchi S; Osaka University Hospital, Osaka, Japan.
  • Toyokawa M; Osaka University Hospital, Osaka, Japan.
  • Kakeya H; Osaka City University Hospital, Osaka, Japan.
  • Fujikawa Y; Osaka City General Hospital, Osaka, Japan.
J Infect Chemother ; 25(9): 657-668, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31196772
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones del Sistema Respiratorio / Farmacorresistencia Bacteriana / Monitoreo Epidemiológico / Antibacterianos Tipo de estudio: Guideline / Risk_factors_studies / Screening_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones del Sistema Respiratorio / Farmacorresistencia Bacteriana / Monitoreo Epidemiológico / Antibacterianos Tipo de estudio: Guideline / Risk_factors_studies / Screening_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article